06th February, 2024
MicroPort EverPace's latest generation Columbus™ 3D EP Navigation System (Columbus™) has recently received CE MDR approval.
The 3D EP Navigation System represents a groundbreaking advancement in tachyarrhythmia treatment. This system merges hardware circuits, software systems, and core algorithms, resulting in a lengthy R&D cycle and high technical barriers. To fulfill clinical needs for high precision, stability, and reliability, the system places high expectations on its components and overall structure.
The latest generation Columbus™ System includes two models. The EPE-SYS-2A, building upon its predecessor, adds an electrical positioning module and offers a new software interface more closely aligned with clinical needs. The Model EPE-SYS-1A features a completely new system architecture. It boasts enhanced signal processing capabilities, more electrode positioning and signal channels. Additionally, it integrates a direct catheter interface, electromagnetic positioning, ECG signal acquisition, and other modules, meeting higher precision clinical needs and providing more valuable information for clinical applications.
To date, the Columbus™ system has successfully completed over 50,000 tachyarrhythmia treatments. In the future, MicroPort EverPace will remain committed to providing more high-quality and innovative products to the global market, ensuring comprehensive electrophysiology treatment and diagnostic solution for patients worldwide.
Medtech Special
Artificial Intelligence Breakthroughs
Robots In Medtech
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer